A Study of Patient Perception and Quality of Life Associated With the Use of Olopatadine 0.2% in Subjects With Allergic Conjunctivitis
Clinical trial NCT01272089 · COMPLETED
Trial details
- NCT number
- NCT01272089
- Sponsor
- Alcon Research
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.